Lycopene: Features and potential significance in the oral cancer and precancerous lesions

Journal of Oral Pathology and Medicine

Volumn 40, Issue 5, 2011, Pages 361-368

  Lu, Rui ^a,b   Dan, Hongxia ^a   Wu, Ruiqing ^a   Meng, Wenxia ^a   Liu, Na ^a   Jin, Xin ^a   Zhou, Min ^a   Zeng, Xin ^a   Zhou, Gang ^b   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Leukoplakia; Lycopene; Oral cancer; Oral precancer; Submucous fibrosis

Indexed keywords

CAROTENOID; LYCOPENE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL; CARDIOVASCULAR DISEASE; DRUG ACTIVITY; FRUIT; GENE FUNCTION; HUMAN; LEUKOPLAKIA; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; REVIEW; TOMATO;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CAROTENOIDS; GAP JUNCTIONS; HUMANS; LEUKOPLAKIA, ORAL; LIPID PEROXIDATION; LYCOPERSICON ESCULENTUM; MOUTH NEOPLASMS; ORAL SUBMUCOUS FIBROSIS; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS;

EID: 79954473682     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00991.x     Document Type: Review

References (68)

1. Khalili J. Oral cancer: risk factors, prevention and diagnostic. Exp Oncol 2008; 30: 259-64.
2. Jiang L, Zeng X, Yang H, et al. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma. Int J Cancer 2008; 123: 1779-86.
3. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-44.
4. Kupferman ME, Myers JN. Molecular biology of oral cavity squamous cell carcinoma. Otolaryngol Clin North Am 2006; 39: 229-47.
5. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002; 52: 195-215.
6. Zhao D, Xu QG, Chen XM, Fan MW. Human papillomavirus as an independent predictor in oral squamous cell cancer. Int J Oral 2009; 1: 119-25.
7. Winn DM. Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr 1995; 61: 437S-45S.
8. Marshall JR, Boyle P. Nutrition and oral cancer. Cancer Causes Control 1996; 7: 101-11.
9. Franceschi S, Bidoli E, Barón AE, et al. Nutrition and cancer of the oral cavity and pharynx in north-east Italy. Int J Cancer 1991; 47: 20-5.
10. Zhou Y, Jiang L, Lin J, Zeng X, Chen Q. The prevalence of hepatitis C virus infection in oral lichen planus in an ethnic Chinese cohort of 232 patients. Int J Oral Sci 2010; 2: 90-7.
11. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999; 91: 317-31.
12. Story EN, Kopec RE, Schwartz SJ, Harris GK. An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol 2010; 1: 189-210.
13. Seren S, Mutchnick M, Hutchinson D, et al. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma. Nutr Cancer 2008; 60: 729-35.
14. Rao AV, Fleshner N, Agarwal S. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study. Nutr Cancer 1999; 33: 159-64.
15. Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. CMAJ 2000; 163: 739-44.
16. Kumar A, Bagewadi A, Keluskar V, Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 207-13.
17. Singh M, Krishanappa R, Bagewadi A, Keluskar V. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol 2004; 40: 591-6.
18. Gupta PC, Hebert JR, Bhonsle RB, Sinor PN, Mehta H, Mehta FS. Dietary factors in oral leukoplakia and submucous fibrosis in a population-based case control study in Gujarat, India. Oral Dis 1998; 4: 200-6.
19. Mayne ST, Cartmel B, Lin H, Zheng T, Goodwin WJ Jr. Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx or larynx cancers. J Am Coll Nutr 2004; 23: 34-42.
20. Livny O, Kaplan I, Reifen R, Polak-Charcon S, Madar Z, Schwartz B. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J Nutr 2002; 132: 3754-9.
21. Clinton SK, Emenhiser C, Schwartz SJ, et al. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev 1996; 5: 823-33.
22. Ferruzzi MG, Nguyen ML, Sander LC, Rock CL, Schwartz SJ. Analysis of lycopene geometrical isomers in biological microsamples by liquid chromatography with coulometric array detection. J Chromatogr B Biomed Sci Appl 2001; 760: 289-99.
23. Boileau TW, Boileau AC, Erdman JW Jr. Bioavailability of all-trans and cis-isomers of lycopene. Exp Biol Med (Maywood) 2002; 227: 914-9.
24. Hadley CW, Clinton SK, Schwartz SJ. The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr 2003; 133: 727-32.
25. Stahl W, Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 1992; 122: 2161-6.
26. Unlu NZ, Bohn T, Francis DM, Nagaraja HN, Clinton SK, Schwartz SJ. Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. Br J Nutr 2007; 98: 140-6.
27. Failla ML, Chitchumroonchokchai C, Ishida BK. In vitro micellarization and intestinal cell uptake of cis isomers of lycopene exceed those of all-trans lycopene. J Nutr 2008; 138: 482-6.
28. Erdman JW Jr, Bierer TL, Gugger ET. Absorption and transport of carotenoids. Ann N Y Acad Sci 1993; 691: 76-85.
29. Gärtner C, Stahl W, Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 1997; 66: 116-22.
30. Bramley PM. Is lycopene beneficial to human health? Phytochemistry 2000; 54: 233-6.
31. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998; 56(2 Pt 1): 35-51.
32. Nierenberg DW, Nann SL. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nutr 1992; 56: 417-26.
33. Stahl W, Schwarz W, Sundquist AR, Sies H. Xcis-trans isomers of lycopene and beta-carotene in human serum and tissues. Arch Biochem Biophys 1992; 294: 173-7.
34. Franceschi S, Bidoli E, La VecchiaC, Talamini R, D'Avanzo B, Negri E. Tomatoes and risk of digestive-tract cancers. Int J Cancer 1994; 59: 181-4.
35. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002; 94: 391-8.
36. Rao AV, Ray MR, Rao LG. Lycopene. Adv Food Nutr Res 2006; 51: 99-164.
37. Trumbo PR. Are there adverse effects of lycopene exposure? J Nutr 2005; 135: 2060S-1S.
38. Stahl W, Sies H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 1996; 336: 1-9.
39. van Breemen RB, Pajkovic N. Multitargeted therapy of cancer by lycopene. Cancer Lett 2008; 269: 339-51.
40. Ukai N, Lu Y, Etoh H. Photosensitized oxygenation of lycopene. Biosci Biotechnol Biochem 1994; 58: 1718-9.
41. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989; 274: 532-8.
42. Burton GW, Ingold KU. beta-Carotene: an unusual type of lipid antioxidant. Science 1984; 224: 569-73.
43. Woodall AA, Britton G, Jackson MJ. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: relationship between carotenoid structure and protective ability. Biochim Biophys Acta 1997; 1336: 575-86.
44. Heber D, Lu QY. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 2002; 227: 920-3.
45. Zhang LX, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991; 12: 2109-14.
46. Zhang LX, Cooney RV, Bertram JS. Carotenoids up-regulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res 1992; 52: 5707-12.
47. Matsushima NR, Shidoji Y, Nishiwaki S, Yamada T, Moriwaki H, Muto Y. Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes. Lipids 1995; 30: 1029-34.
48. Brienholt V, Lauridsen ST, Daneehvar B, Jakobeen J. Dose-responses effects of lycopene on selected drug metabolizing and antioxidant enzymes in rat. Cancer Lett 2004; 154: 201-10.
49. Kobayashi T, Iijima K, Mitamura T, Toriizuka K, Cyong JC, Nagasawa H. Effects of lycopene, a carotenoid, on intrathymic T cell differentiation and peripheral CD4/CD8 ratio in a high mammary tumor strain of SHN retired mice. Anticancer Drugs 1996; 7: 195-8.
50. Nagasawa H, Mitamura T, Sakamoto S, Yamamoto K. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res 1995; 15: 1173-8.
51. Rajendran R. Oral submucous fibrosis: etiology, pathogenesis, and future research. Bull World Health Organ 1994; 72: 985-96.
52. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 2006; 42: 561-8.
53. Kitade Y, Watanabe S, Masaki T, Nishioka M, Nishino H. Inhibition of liver fibrosis in LEC rats by a carotenoid, lycopene, or a herbal medicine, Sho-saiko-to. Hepatol Res 2002; 22: 196-205.
54. Bánóczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ 2001; 65: 322-7.
55. Nagao T, Ikeda N, Warnakulasuriya S, et al. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncol 2000; 36: 466-70.
56. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Systematic review of randomized trials for the treatment of oral leukoplakia. J Dent Educ 2002; 66: 896-902.
57. Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 2004; 34: 379-85.
58. Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci 2005; 9: 361-7.
59. Manoharan S, Kolanjiappan K, Suresh K, Panjamurthy K. Lipid peroxidation & antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res 2005; 122: 529-34.
60. Gokul S, Patil V, Jailkhani R, Hallikeri K, Kattappagari K. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Dis 2010; 16: 29-33.
61. Das S, Kar Mahapatra S, Gautam N, Das A, Roy S. Oxidative stress in lymphocytes, neutrophils, and serum of oral cavity cancer patients: modulatory array of L-glutamine. Support Care Cancer 2007; 15: 1399-405.
62. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 2007; 109: 54-9.
63. Zheng T, Boyle P, Willett WC, et al. A case-control study of oral cancer in Beijing, People's Republic of China. Associations with nutrient intakes, foods and food groups. Eur J Cancer B Oral Oncol 1993; 29B: 45-55.
64. De Stefani E, Oreggia F, Boffetta P, Deneo-Pellegrini H, Ronco A, Mendilaharsu M. Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: a case-control in Uruguay. Oral Oncol 2000; 36: 47-53.
65. Cheng HC, Chien H, Liao CH, Yang YY, Huang SY. Carotenoids suppress proliferating cell nuclear antigen and cyclin D1 expression in oral carcinogenic models. J Nutr Biochem 2007; 18: 667-75.
66. Bhuvaneswari V, Velmurugan B, Nagini S. Dose-response effect of tomato paste on 7, 12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. J Exp Clin Cancer Res 2004; 23: 241-9.
67. Bhuvaneswari V, Abraham SK, Nagini S. Combinatorial antigenotoxic and anticarcinogenic effects of tomato and garlic through modulation of xenobiotic-metabolizing enzymes during hamster buccal pouch carcinogenesis. Nutrition 2005; 21: 726-31.
68. Bhuvaneswari V, Nagini S. Lycopene: a review of its potential as an anticancer agent. Curr Med Chem Anticancer Agents 2005; 5: 627-35.